Mutated blood cells define clinical risks in Langerhans cell histiocytosis

A nationwide team led by researchers at Baylor College of Medicine, Texas Children’s Hospital and UPMC Children’s Hospital of Pittsburgh has proposed a major revision to how Langerhans cell histiocytosis (LCH) is diagnosed and treated after analyzing patients with LCH for several years.

Leave A Comment

Your email address will not be published. Required fields are marked *